43 results on '"Tang, W.H. Wilson"'
Search Results
2. Renal perturbations with sodium–glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction
3. Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling
4. The Utilization and Impact of Cardiovascular Specialists on Guideline‐Directed Medical Scores: An Analysis of a Diverse, Multi‐state, Electronic Health Record‐Based Registry
5. Sodium and potassium changes during decongestion with acetazolamide – a pre‐specified analysis from the ADVOR trial
6. Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
7. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion
8. The effect of intravenous ferric carboxymaltose on right ventricular function – insights from the IRON‐CRT trial
9. Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology
10. Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia
11. Metabolic endophenotype associated with right ventricular glucose uptake in pulmonary hypertension
12. A case series of cardiac amyloidosis patients supported by continuous‐flow left ventricular assist device
13. Identifying sodium non‐excretors : heart failure's emerging golden ticket for risk stratification
14. Impact of body mass index on surgical coronary revascularization for ischaemic heart failure: insights from STICHES
15. Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
16. A means to an end: the promise of tracking natriuresis with diuretic therapy
17. Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA‐HF trial
18. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology
19. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning‐based unsupervised cluster analysis
20. Can saline repletion be the true TARGET for achieving fluid balance in acute heart failure?
21. Temporal association between hospitalization event and subsequent risk of mortality among patients with stable chronic heart failure with preserved ejection fraction: insights from the TOPCAT trial
22. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT
23. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
24. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT
25. I will take my heart failure ‘lactate‐free’ please
26. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF
27. Inflammation and cardio-renal interactions in heart failure: a potential role for interleukin-6
28. Metabolic and Functional Evaluation of the Heart and Lungs in Pulmonary Hypertension by Gated 2‐[18F]‐Fluoro‐2‐deoxy‐D‐glucose Positron Emission Tomography
29. Left Ventricular Size does not Modify the Effect of QRS Duration in Predicting Response to Cardiac Resynchronization Therapy
30. High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure
31. Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial
32. Endothelin-1 is independently associated with 180-day mortality after adjusting for body mass index
33. Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure
34. Probiotic therapy to attenuate weight gain and trimethylamine-N-Oxide generation: A cautionary tale
35. Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure
36. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF
37. A Clinical Prediction Rule to Identify Patients at Heightened Risk for Early Demise Following Cardiac Resynchronization Therapy
38. The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’
39. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment
40. Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians
41. Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study
42. Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure
43. Revisiting the cardio‐renal hypothesis: the pivotal role of the kidney in congestive heart failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.